Portal Biotech Ltd.

A biotechnology startup founded by experts in nanopore sequencing and AI. Portal emerged around 2021 and stayed low-profile until a major funding announcement in 2025. Its mission is to transform proteomics and pathogen detection by leveraging single-molecule technology for field use.